Combating Facial Wasting in Semaglutide Patients: A Guide to Combination Therapy Strategies
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained popularity for its efficacy in managing type 2 diabetes and as an effective weight loss treatment. However, a lesser-discussed side effect, especially with significant weight loss, is facial wasting—often referred to as “Ozempic face.” This condition can lead to a hollowed, aged appearance as facial fat […]